| Literature DB >> 30533445 |
Lidya Ketema1, Zerihun Ketema2, Bitsu Kiflu3, Haile Alemayehu4, Yitagele Terefe5, Mohammed Ibrahim6, Tadesse Eguale4.
Abstract
Salmonella is one of the top causes of foodborne bacterial illnesses in humans. The primary sources of human Salmonella infection are food producing animals such as cattle, poultry, and swine. A cross-sectional study was undertaken to estimate the prevalence and to determine the serovar distribution and antimicrobial susceptibility profiles of Salmonella spp. isolated from fecal (n=567) and carcass swab (n=159) samples of slaughtered cattle at Addis Ababa Abattoir Enterprise and Kara'alo PLC, Abattoirs, in Addis Ababa, Ethiopia between January 2014 and April 2015. Salmonella isolation was conducted according to Global Foodborne Infections Network Laboratory Protocol and isolates were confirmed by genus specific PCR and serotyped by slide agglutination test. Susceptibility of the isolates to 17 antimicrobials was testedusing the Kirby-Bauer disk diffusion method according to the guidelines of the Clinical and Laboratory Standards Institute. Out of the total 726 samples examined, 27 (3.7%) were positive for Salmonella. Salmonella was detected in 4.1% (23/567) fecal and 2.5% (4/159) carcass swab samples. Twelve different serovars were identified and the most predominant serovars were S. Dublin (n=10, 35.7%) and S. Virchow (n=5, 17.9%), followed by S. Braendrerup, S. Haifa, and S. Saintpaul which were isolated from 2 samples each (7.1%). All of the Salmonella isolates investigated were resistant or intermediately resistant to four or more of the 17 drugs tested. High resistance rate was recorded to streptomycin 25 (89.3%), cephalothin 20 (71.4%), ampicillin 19 (67.9%), and amoxicillin+clavulanic acid 19 (67.9%). Resistance to five or more antimicrobials was detected in 20 (71.5%) of the isolates. Multidrug resistance to more than 7 antimicrobials was detected in 5 (17.9%) of the isolates. Isolation of such multidrug resistant strains of Salmonella from slaughtered cattle poses a major public health concern. These findings imply the need for a strict biosecurity and regulation of antimicrobial use across the country.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30533445 PMCID: PMC6247655 DOI: 10.1155/2018/9794869
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Summary of the prevalence of Salmonella and sample types.
|
|
|
|
|
|---|---|---|---|
| Addis Ababa | Fecal | 282 | 11 (3.9%) |
| Swab | 60 | 2 (3.3%) | |
|
| |||
| Subtotal | 342 | 13 | |
|
| |||
| Kara'alo | Fecal | 285 | 12 (4.2%) |
| Swab | 99 | 2 (2.0%) | |
|
| |||
| Subtotal |
|
| |
|
| |||
|
|
|
| |
Salmonella serovars isolated from fecal and swab samples of cattle slaughtered at Addis Ababa, Ethiopia.
| Serovars | Antigenic formula | No. isolated from each Abattoirs | Total (%) | |
|---|---|---|---|---|
| Addis Ababa | Kara'alo | |||
| Dublin | 9,12:g,p:- | 0 | 10 | 10 (35.7) |
| Virchow | 6,7:r:1,2 | 2 | 3 | 5 (17.9) |
| Braendrerup | 6,7:e,h:e,n,z15 | 2 | 0 | 2 (7.1) |
| Saintpaul | 4:e,h:1,2 | 2 | 0 | 2 (7.1) |
| Haifa | 4:z10:1,2 | 2 | 0 | 2 (7.1) |
| Kottbus | 6,8:e,h:1,5 | 1 | 0 | 1 (3.6) |
| Kentucky | 8,20:i:z6 | 1 | 0 | 1 (3.6) |
| Mikawasima | 6,7:y:e,n,z15 | 1 | 0 | 1 (3.6) |
| Typhimurium phage type 3 | 4,5:i:1,2 | 1 | 0 | 1 (3.6) |
| Typhimurium phage type 193 | 4,5:i:1,2 | 1 | 0 | 1 (3.6) |
| Typhimurium phage type 4 | 4,5:i:1,2 | 1 | 0 | 1 (3.6) |
| I:ROUGH-O:g,p:- | -:g,p:- | 0 | 1 | 1 (3.6) |
|
| ||||
|
|
| |||
Salmonella serovar distribution and frequency of resistance to various antimicrobials.
| Antimicrobials tested |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dublin | Virchow | Typhimurium | Saintpaul | Braenderup | Haifa | Kottbus | Kentucky | Mikawasima | I:ROUGH-O:g,p:- | No. (%) resistant | |
| n=10 | n=5 | n=3 | n=2 | n=2 | n=2 | n=1 | n=1 | n=1 | n=1 | ||
| Amp | 10 (100) | 3 (60) | 2 (66.7) | 2 (100) | - | - | - | 1 (100) | - | 1 (100) | 19 (67.9) |
| Amc | 10 (100) | 3 (60) | 2 (66.7) | 2 (100) | - | - | - | 1 (100) | - | 1 (100) | 19 (67.9) |
| Cf | 10 (100) | 3 (60) | 2 (66.7) | 2 (100) | - | - | 1 (100) | 1 (100) | - | 1 (100) | 20 (71.4) |
| Cro | - | - | - | - | - | - | - | - | 0 | ||
| Fox | 1 (10) | - | - | - | - | - | - | 1 (100) | 2 (7.1) | ||
| An | - | 1 (20) | - | - | 1 (50) | 1 (50) | - | - | 1 (100) | - | 4 (14.3) |
| Gm | 1 (10) | - | - | - | - | - | 1 (100) | - | - | 2 (7.1) | |
| K | 3 (30) | 5 (100) | 2 (66.7) | 1 (50) | 1 (50) | 2 (100) | 1 (100) | 1 (100) | - | - | 16 (57.1) |
| S | 10 (100) | 5 (100) | 2 (66.7) | 2 (100) | 2 (100) | 1 (50) | 1 (100) | 1 (100) | 1 (100) | - | 25 (89.3) |
| Sxt | - | - | 1 (33.3) | - | - | - | - | - | - | - | 1 (3.6) |
| Cip | - | 1 (20) | 2 (66.7) | 2 (100) | 2 (100) | 1 (50) | - | 1 (100) | 1 (100) | - | 10 (35.7) |
| Na | 1 (10) | - | - | - | - | - | - | 1 (100) | - | 2 (7.1) | |
| Te | - | 2 (40) | 1 (33.3) | 2 (100) | 2 (100) | 1 (50) | 1 (100) | 1 (100) | 1 (100) | - | 11 (39.3) |
| C | - | - | - | - | - | - | - | - | - | - | 0 |
| Tmp | 1 (10) | - | 1 (33.3) | - | - | - | - | - | - | - | 2 (7.1) |
| Su | 1 (10) | 2 (40) | - | 2 (100) | 2 (100) | 2 (100) | 1 (100) | 1 (100) | 1 (100) | - | 12 (42.9) |
| Nitro | - | 2 (40) | 2 (66.7) | - | 1 (50) | 2 (100) | 1 (100) | 1 (100) | 1 (100) | - | 10 (35.7) |
An: amikacin, Amp: ampicillin, Amc: amoxicillin+clavulanic acid, C: chloramphenicol, Cro: ceftrioxone, Cf: cephalothin, Cip: ciprofloxacin, Fox: cefoxitin, Gm: gentamicin, K: kanamycin, Sxt: sulfamethoxazole+trimethoprim, Tmp: trimethoprim, Te: tetracycline, Suv: sulfisoxazole, S: streptomycin, Nitro: nitrofurantoin, and Na: nalidixic acid. ∗Isolates intermediately resistant were also considered resistant.
Antimicrobial resistance pattern of Salmonella serovars isolated from slaughtered cattle.
| Serovar |
| Resistance Pattern | |
|---|---|---|---|
| Intermediate | Resistant | ||
| Braendrerup | 1 | Cip,Te,Su,S | - |
| Braendrerup | 1 | An,Cip,K,Te,Su,S | Nitro |
| Dublin | 2 | K | Amp,Amc,Cf,S |
| Dublin | 2 | S | Amp,Amc,Cf |
| Dublin | 1 | S | Amp,Amc,Cf,Gm |
| Dublin | 1 | S,Su,Tmp | Amp,Amc,Cf |
| Dublin | 1 | S | Amp,Amc,Cf |
| Dublin | 1 | - | Amp,Amc,Cf,S |
| Dublin | 1 | Fox,K | Amp,Amc,Cf,S |
| Dublin | 1 | Na,S | Amp,Amc,Cf |
| Haifa | 1 | K,Nitro | Te,Su |
| Haifa | 1 | An,Cip,K,Su,S,Nitro | - |
| Kottbus | 1 | Cf,K,S | Te,Su,Nitro |
| Kentucky | 1 | K,Nitro | Amp,Amc,Cf,Cip,Gm,Te,Su,S,Na |
| Mikawasima | 1 | An,Cip,Te | Su,S,Nitro |
| Saintpaul | 1 | Amc,Cip,K,Su,S | Amp,Cf, Te |
| Saintpaul | 1 | Amp,Amc,Cf,Cip,Su,S | Amp,Cf,Te |
| Typhimurium phage type 3 | 1 | Cip,K,Nitro,S | Amp,Amc,Cf |
| Typhimurium phage type 93 | 1 | - | Sxt,Tmp,Te,S |
| Typhimurium phage type 4 | 1 | Cip,K,Nitro | Amp,Amc,Cf |
| Virchow | 1 | K,Te,Su,S | Nitro |
| Virchow | 1 | Cip,K,Te,Su,S,Nitro | - |
| Virchow | 1 | An, K | Amp,Amc,Cf,S |
| Virchow | 2 | K,S | Amp,Amc,Cf |
| I:ROUGH-O:g,p:- | 1 | Fox | Amp,Amc,Cf |
An, amikacin; Amp, ampicillin; Amc, amoxicillin and clavulanic acid; Cf, cephalothin; C, chloramphenicol; Cro, ceftriaxone; Cip, ciprofloxacin; Fox, cefoxitin; Gm, gentamicin; K, kanamycin; Tmp, trimethoprim; Sxt, sulfamethoxazole + trimethoprim; Te, tetracycline; Su, sulfisoxazole; S, streptomycin; Nitro, nitrofurantoin; Na, nalidixic acid, N, neomycin.